Finland· FI-REL-REL36720
Vpriv
A velaglucerase alfa product containing velaglucerase alfa, registered in Finland by Shire Pharmaceuticals Ireland Ltd.. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Velaglucerase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB10 (velaglucerase alfa), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Velaglucerase alfa · ATC A16AB10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Velaglucerase alfa
- Manufacturer
- Shire Pharmaceuticals Ireland Ltd.
- Country
- Finland (FI)
- ATC code
- A16AB10
- ATC class
- Velaglucerase alfa
- Defined daily dose
- 300 E, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Velaglucerase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVpriv 200 IUShire Pharmaceuticals Ireland
- CzechiaVPRIVTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SwedenVPRIV 200 E Pulver till infusionsvätska, lösningShire Pharmaceuticals Ireland Limited
- FranceVPRIV 400 unités, poudre pour solution pour perfusionTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- United KingdomVPRIV 400units powder for solution for infusion vialsTakeda UK Ltd
- IrelandVPRIV 400 Units powder for solution for infusionShire Pharmaceuticals Ireland Limited
- IcelandVPRIVTakeda Pharmaceuticals International AG Ireland Branch
- Japanベラグルセラーゼ アルファ（遺伝子組換え）武田薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vpriv
- Liechtenstein · Vpriv
- Norway · Vpriv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/29a16902-59cc-4486-aaf9-b36c9ed98f26 GET /v1/drugs/29a16902-59cc-4486-aaf9-b36c9ed98f26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "300",
"form": "infuusiokuiva-aine, liuosta varten",
"route": null,
"ddd_unit": "U",
"strength": "200 U",
"atc_label": "velagluseraasi alfa",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/10/646/1,3-4",
"fimea_rel_id": "REL36720",
"authorised_at": "2010-08-26"
}See everything about velaglucerase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.